HE4 expression in endometrial cancer was 76.32% at stage Ia, 91.30% at stage Ib, 71.43% at stage II, 96.43% at stage III, and 100.00% at stage IV, respectively, which showed an increasing tendency with increased clinical stage. The gene discussed is WFDC2; the disease is endometrial cancer.